AnnouncementÖssur hf. No. 3/2010
Reykjavik, 4 February 2010
SOLID OPERATIONS - 2009
Highlights:
* Sales USD331 million
* Gradual increase in sales during the year
* EBITDAmargin 20%
* Strong performance in Prosthetics
* Second generation of Bionics launched
* Enhanced sales platform in place
* Listing on NASDAQ OMX Copenhagen
Guidance 2010:
* Sales 3-4% LCY growth
* EBITDA 8-10% LCY growth
Jon Sigurdsson, President & CEO, comments:
"The results for 2009 are good and show clearly the Company's strength. During
the year we have seen the global economic turmoil having an impact on our
customers and affecting some of our markets. However, Össur continues to
beprofitable and operations are sound. Our Bionic product line has gained
further momentum through the launch of the second generation of the RHEO KNEE as
well as the acceptance of the PROPRIO FOOT into the US reimbursement systems. In
2009 we have invested significantly in aligning our B&S business to take
advantage of the prevailing market opportunity. We believe that 2010 will be an
exciting year for Össur."
Össur Investor Meeting Thursday 4 February in Copenhagen
- Live webcast at 12:00 CET/ 11:00 GMT/ 6:00 EST
Thursday 4 February 2010Jon Sigurdsson, President and CEO, and Hjorleifur
Palsson, CFO, will host a meeting for investors, analysts and shareholders
presenting and discussing the results of the fourth quarter and the year 2009.
The meeting will be held in Copenhagen at the Radisson Blu Royal Hotel,
Hammerichsgade 1, Copenhagen. The meeting will be conducted in English.
There will be a live broadcast from the meeting on the Össur
website:www.ossur.com/investors <http://www.ossur.com/investors>
To participate in the meeting please call one of the following telephone
numbers:
Europe:+ 44 (0) 207 509 5139
The United States: +1 718 354 1226
Iceland:800 9313
[HUG#1380514]
